









Markets
/
Stocks
/
nasdaq-mbot
/

Microbot Medical Inc

MBOT

2.295USD

-0.325-12.41%

Market hours （ET）Quotes delayed by 15 min

33.21KMarket Cap

LossP/E TTM



Microbot Medical Inc

2.295

-0.325-12.41%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Microbot Medical Inc

Currency: USD Updated: 2026-03-27

Key Insights

Microbot Medical Inc's fundamentals are relatively weak, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 141 out of 391 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 7.50.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Microbot Medical Inc's Score

Industry at a Glance

Industry Ranking

141 / 391

Overall Ranking

264 / 4542

Industry

Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Microbot Medical Inc Highlights

StrengthsRisks

Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 0.00.

Undervalued

The company’s latest PE is -8.33, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 10.98M shares, increasing 29.88% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 3.33M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of -0.02.

Analyst Rating

Based on 3 analysts

Buy

Current Rating

7.500

Target Price

+186.26%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Microbot Medical Inc is 5.51, ranking 351 out of 391 in the Biotechnology & Medical Research industry. Its financial status is weak, and its operating efficiency is low.

Score

Industry at a Glance

Previous score

5.51

Change



Financials

2.04

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.75

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

4.00

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.75

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.03

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Microbot Medical Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Microbot Medical Inc is 7.00, ranking 186 out of 391 in the Biotechnology & Medical Research industry. Its current P/E ratio is -8.33, which is -92.60% below the recent high of -0.62 and 0.00% above the recent low of -8.33.

Score

Industry at a Glance

Previous score

7.00

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 141/391

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Microbot Medical Inc is 8.00, ranking 163 out of 391 in the Biotechnology & Medical Research industry. The average price target is 8.75, with a high of 12.00 and a low of 5.50.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 3 analysts

Buy

Current Rating

7.500

Target Price

+186.26%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

548

Total

Median

Average

Company name

Ratings

Analysts

Microbot Medical Inc

MBOT

CRISPR Therapeutics AG

CRSP

IQVIA Holdings Inc

IQV

argenx SE

ARGX

Intellia Therapeutics Inc

NTLA

Beigene Ltd

ONC

...

110

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Microbot Medical Inc is 6.84, ranking 124 out of 391 in the Biotechnology & Medical Research industry. Currently, the stock price is trading between the resistance level at 2.74 and the support level at 2.15, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.82

Change

-1.98

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.078

Neutral

RSI(14)

46.390

Neutral

STOCH(KDJ)(9,3,3)

21.908

Neutral

ATR(14)

0.171

Low Volatility

CCI(14)

-128.693

Sell

Williams %R

92.079

Oversold

TRIX(12,20)

0.611

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

2.512

Sell

MA10

2.584

Sell

MA20

2.559

Sell

MA50

2.248

Buy

MA100

2.195

Buy

MA200

2.573

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Microbot Medical Inc is 3.00, ranking 195 out of 391 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 16.35%, representing a quarter-over-quarter increase of 71.16%. The largest institutional shareholder is The Vanguard, holding a total of 3.33M shares, representing 4.96% of shares outstanding, with 132.42% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

2.34M

+14.28%

CIBC Private Wealth Advisors, Inc.

1.45M

+137.58%

Susquehanna International Group, LLP

1.25M

+3826.08%

BlackRock Institutional Trust Company, N.A.

483.69K

+54.06%

Geode Capital Management, L.L.C.

493.39K

+24.90%

DNB Asset Management AS

243.63K

+26.37%

UBS Financial Services, Inc.

188.20K

+353.30%

Stifel, Nicolaus & Company, Incorporated

157.17K

+895.77%

State Street Investment Management (US)

208.47K

+50.50%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Biotechnology & Medical Research domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Microbot Medical Inc is 3.58, ranking 131 out of 391 in the Biotechnology & Medical Research industry. The company's beta value is 1.16. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.